KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 184 | 3 | 1 | −180 |
| Shares | 69.3M | 11.8K | 7 | −69.2M (−100.0%) |
| Value | $1.39B | $237.8K | $189 | −$1.39B (−100.0%) |
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 7 | $189 | 0.00% |
Sold out (181)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
Showing the largest 100 of 181 by value.
Not filed for Q2 2026 yet (3)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 10,900 | $219.5K |
| CWM, LLC | 901 | $18.1K |
| Sunbelt Securities, Inc. | 9 | $181 |